166 related articles for article (PubMed ID: 27989931)
1. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.
Battiwalla M; Hashmi S; Majhail N; Pavletic S; Savani BN; Shelburne N
Biol Blood Marrow Transplant; 2017 Jan; 23(1):6-9. PubMed ID: 27989931
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
[TBL] [Abstract][Full Text] [Related]
3. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.
Shaw BE; Hahn T; Martin PJ; Mitchell SA; Petersdorf EW; Armstrong GT; Shelburne N; Storer BE; Bhatia S
Biol Blood Marrow Transplant; 2017 Jan; 23(1):10-23. PubMed ID: 27590102
[TBL] [Abstract][Full Text] [Related]
4. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
Hashmi SK; Bredeson C; Duarte RF; Farnia S; Ferrey S; Fitzhugh C; Flowers MED; Gajewski J; Gastineau D; Greenwald M; Jagasia M; Martin P; Rizzo JD; Schmit-Pokorny K; Majhail NS
Biol Blood Marrow Transplant; 2017 May; 23(5):717-725. PubMed ID: 27713091
[TBL] [Abstract][Full Text] [Related]
5. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
[TBL] [Abstract][Full Text] [Related]
6. Managing Survivorship after Hematopoietic Cell Transplantation.
Khera N
Curr Hematol Malig Rep; 2023 Jun; 18(3):75-82. PubMed ID: 36995660
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.
Gea-Banacloche J; Komanduri KV; Carpenter P; Paczesny S; Sarantopoulos S; Young JA; El Kassar N; Le RQ; Schultz KR; Griffith LM; Savani BN; Wingard JR
Biol Blood Marrow Transplant; 2017 Jun; 23(6):870-881. PubMed ID: 27751936
[TBL] [Abstract][Full Text] [Related]
8. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
[TBL] [Abstract][Full Text] [Related]
9. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.
Armenian SH; Chemaitilly W; Chen M; Chow EJ; Duncan CN; Jones LW; Pulsipher MA; Remaley AT; Rovo A; Salooja N; Battiwalla M
Biol Blood Marrow Transplant; 2017 Feb; 23(2):201-210. PubMed ID: 27590105
[TBL] [Abstract][Full Text] [Related]
10. Long-term complications after hematopoietic cell transplantation.
Majhail NS
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):220-227. PubMed ID: 28641097
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.
Tamburro RF; Cooke KR; Davies SM; Goldfarb S; Hagood JS; Srinivasan A; Steiner ME; Stokes D; DiFronzo N; El-Kassar N; Shelburne N; Natarajan A;
Ann Am Thorac Soc; 2021 Mar; 18(3):381-394. PubMed ID: 33058742
[TBL] [Abstract][Full Text] [Related]
12. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957
[TBL] [Abstract][Full Text] [Related]
13. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.
Nieder ML; McDonald GB; Kida A; Hingorani S; Armenian SH; Cooke KR; Pulsipher MA; Baker KS
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1573-84. PubMed ID: 21963877
[TBL] [Abstract][Full Text] [Related]
14. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
Majhail NS; Rizzo JD
Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
[TBL] [Abstract][Full Text] [Related]
15. Reprint of: Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.
Battiwalla M; Tichelli A; Majhail NS
Biol Blood Marrow Transplant; 2017 Mar; 23(3S):S1-S9. PubMed ID: 28236836
[TBL] [Abstract][Full Text] [Related]
16. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in survivors of hematopoietic cell transplantation.
Armenian SH; Chow EJ
Cancer; 2014 Feb; 120(4):469-79. PubMed ID: 24166350
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.
Battiwalla M; Tichelli A; Majhail NS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):184-192. PubMed ID: 27818318
[TBL] [Abstract][Full Text] [Related]
19. Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop.
Gallicchio L; Tonorezos E; de Moor JS; Elena J; Farrell M; Green P; Mitchell SA; Mollica MA; Perna F; Saiontz NG; Zhu L; Rowland J; Mayer DK
J Natl Cancer Inst; 2021 Sep; 113(9):1136-1142. PubMed ID: 33755126
[TBL] [Abstract][Full Text] [Related]
20. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
Dvorak CC; Gracia CR; Sanders JE; Cheng EY; Baker KS; Pulsipher MA; Petryk A
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1725-38. PubMed ID: 22005649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
